We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Anterix
ATEX
$1.94B
| $905K | ﹤0.01% |
15,406
-190
| -1% | -$11.5K |
|
2252
IDEAYA Biosciences
IDYA
$3.56B
| $902K | ﹤0.01% |
38,147
+2,887
| +8% | +$67.1K |
|
|
LOVE
2253
LoveSac
LOVE
$261M
| $897K | ﹤0.01% |
13,540
+692
| +5% | +$50.7K |
|
2254
Castle Biosciences
CSTL
$979M
| $896K | ﹤0.01% |
20,898
-357
| -2% | -$18.7K |
|
|
CELL
2255
DELISTED
PhenomeX Inc. Common Stock
CELL
| $891K | ﹤0.01% |
49,028
-802
| -2% | -$17.3K |
|
|
ALX
2256
Alexander's
ALX
$1.41B
| $889K | ﹤0.01% |
3,416
-38
| -1% | -$10.2K |
|
2257
iShares Russell 2000 Value ETF
IWN
$14.6B
| $882K | ﹤0.01% |
5,310
-282
| -5% | -$47K |
|
|
MRC
2258
DELISTED
MRC Global
MRC
| $880K | ﹤0.01% |
127,927
-86
| -0.1% | -$673 |
|
2259
Ocugen
OCGN
$434M
| $880K | ﹤0.01% |
193,340
-2,810
| -1% | -$21.2K |
|
|
GOEV
2260
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $880K | ﹤0.01% |
248
+8
| +3% | +$31.9K |
|
2261
Bionano Genomics
BNGO
$13.3M
| $879K | ﹤0.01% |
490
-4
| -0.8% | -$10.7K |
|
2262
VSE Corp
VSEC
$6.12B
| $875K | ﹤0.01% |
14,366
-162
| -1% | -$9.06K |
|
|
XENT
2263
DELISTED
Intersect ENT, Inc
XENT
| $868K | ﹤0.01% |
31,792
-6,112
| -16% | -$166K |
|
2264
First Financial Corp
THFF
$969M
| $867K | ﹤0.01% |
19,141
+359
| +2% | +$15.8K |
|
|
FRTA
2265
DELISTED
Forterra, Inc
FRTA
| $862K | ﹤0.01% |
36,257
-683
| -2% | -$16.3K |
|
2266
Tucows
TCX
$175M
| $859K | ﹤0.01% |
10,253
-162
| -2% | -$13.5K |
|
|
CFB
2267
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $856K | ﹤0.01% |
54,821
-492
| -0.9% | -$7.15K |
|
|
PYCR
2268
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $851K | ﹤0.01% |
29,530
+17,229
| +140% | +$544K |
|
2269
Mercantile Bank Corp
MBWM
$1.05B
| $848K | ﹤0.01% |
24,194
-96
| -0.4% | -$3.34K |
|
2270
Utz Brands
UTZ
$1.25B
| $848K | ﹤0.01% |
53,158
-797
| -1% | -$12.7K |
|
|
TRHC
2271
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $848K | ﹤0.01% |
56,532
+2,070
| +4% | +$37.7K |
|
2272
Stoneridge
SRI
$213M
| $846K | ﹤0.01% |
42,869
-473
| -1% | -$10K |
|
2273
MeiraGTx Holdings
MGTX
$1.21B
| $842K | ﹤0.01% |
35,447
+433
| +1% | +$8.29K |
|
2274
Microvision
MVIS
$78.9M
| $842K | ﹤0.01% |
11,207
-134
| -1% | -$16K |
|
2275
V2X
VVX
$2.65B
| $842K | ﹤0.01% |
18,392
-209
| -1% | -$9.91K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.